Table 5.

Association between plasma 25-OHD levels (ng/mL) and breast cancer risk by tumor ER and PR status

Plasma 25-OHD (ng/mL)ControlsER+ and/or PR+ (n = 538)ER−/PR− (n = 131)ER/PR unknown (n = 355)
No.OR (95% CI)No.OR (95% CI)No.OR (95% CI)
<203021751.00491.001181.00
20-292871310.86 (0.72-1.00)330.83 (0.59-1.07)1090.94 (0.78-1.10)
30-392951630.95 (0.81-1.09)340.82 (0.58-1.06)890.84 (0.67-1.01)
≥40191690.78 (0.60-0.96)150.67 (0.35-0.99)390.67 (0.46-0.88)

NOTE: Adjusted for age, race, BMI, and season of blood draw.